Background. Spinal stenosis is characterized by narrowing of the spinal canal, with mechanical compression of spinal nerve roots. The latter may cause low back pain and/or leg pain, as well as neurogenic claudication. Epidural steroid injection is commonly used to treat patients with lumbar spinal stenosis (LSS), but percutaneous epidural adhesiolysis has been utilized when symptoms prove refractory. Our goal was to assess the relationship between improvement shown on epidurogram and subjective patient response to adhesiolysis.
Methods. For this prospective study, 78 patients with degenerative LSS were enrolled. Each subject underwent magnetic resonance imaging of the lumbar spine, with all therapeutic procedures conducted in the operating room. Two weeks later, a second epidurography was performed. Second epidurography was conducted to assess any change in epidural filling defects. Outcome measures were obtained using the visual analogue scale (VAS) score at two weeks, one month, and three months post-treatment.
Results. All of the 78 study participants (mean age 5 60.9 years, range 5 34-85 years) displayed epidural filling defects at baseline. After percutaneous adhesiolysis, epidurographic filling defects were absent in 73% of patients. In the presence or absence of filling defects, mean VAS scores were 5.2 and 4.5, respectively, at two weeks' follow-up. No significant correlation between postprocedural VAS score and status of filling defects (yes or no) was evident during the three-month follow-up period.
Conclusion. In patients with LSS, epidurographic findings following percutaneous epidural adhesiolysis failed to correlate with level of pain reduction achieved.
Introduction
Lumbar spinal stenosis (LSS) is a common degenerative narrowing of the spinal canal, developing as a consequence of both bony and soft tissue changes and resulting in mechanical compression of spinal nerve roots. When symptomatic, weakness, reflex alterations, gait disturbances, bowel or bladder dysfunction, motor and sensory changes, and neurogenic claudication may be manifested [1] .
Treatment modalities for use with LSS vary but may include medication, exercise, steroid injections, and surgery [2] . Percutaneous epidural adhesiolysis has been used in conditions of refractory chronic low back pain or following failed back surgery syndrome [3, 4] . The goal of adhesioysis is to ablate aberrant adhesions, facilitating delivery of medication to the area of need. In patients with spinal stenosis, percutaneous adhesiolysis procedures offer the combination of local anesthetic delivery, steroid administration, and hypertonic sodium chloride solution injection, all delivered in a targeted manner [5] .
Most studies have shown that adhesiolysis is an effective treatment of low back pain and/or cervical radicular pain [6] [7] [8] . Park et al. [6] reported that significant pain relief was achieved in 66% of patients with LSS six months after undergoing adhesiolysis. Although they found no correlation with between severity of spinal stenosis and pain relief [6, 7] , spondylolisthesis, prior lumbar surgery, and foraminal stenosis were associated with poor outcomes following percutaneous adhesiolysis [9] .
The presence or absence of a postprocedural filling defect is generally considered an important factor. One publication in particular maintains that discernible improvement in postneuroplasty epidurogram and goodquality pain relief are related. In all patients experiencing lower back pain, with or without leg pain, the contrast dispersion pattern observed during caudal epidurography correlated significantly with severity of pain, but not with laterality [10] . Accordingly, our aim was to investigate the relationship between postadhesiolysis epidurographic change and patient outcome.
Methods
A total of 78 patients with degenerative LSS were enrolled in this prospective study. The protocol was approved by our institutional review board, and all patients granted signed informed consent. The inclusion criterion for the current study was that all of the patients had to have symptoms typical of lumbar spinal stenosis, that is, low back pain (medial branch block negative) and neurogenic spinal claudication (leg pain on walking), with clear evidence of central canal stenosis on the cross-sectional images from the spinal MRI. The following criteria were grounds for exclusion: 1) vague symptom descriptions; 2) leg pain that is not aggravated by walking; 3) low back pain that occurrs during pressure of paraspinal muscle (due to role our face t joint pain); 4) extraforaminal stenosis on cross-sectional images; 5) spondylolisthesis; and 6) previous back surgery.
Prior to each therapeutic procedure, transforaminal epidurography was done to identify filling defects at corresponding levels of symptoms and MRI abnormalities. After sterile preparation and draping were carried out, local anesthesia was administered by gently advancing a 23 g, 3.5-inch spinal needle under fluoroscopic guidance (in oblique view) to the safe triangle, formed by the pedicle, a tangential base at the exiting nerve root, and the lateral border of the vertebral body. Both anteroposterior and lateral fluoroscopic projections confirmed proper needle placement. At each level, 1-5 mL of contrast medium (OMNIPAQUE; GE Healthcare, Waukesha, WI, USA) was injected to confirm its position. Once contrast was verified at the target area, filling defects were assessed using real-time fluoroscopy.
All percutaneous adhesiolysis procedures were performed in operating rooms. In prone position, the site of needle insertion was prepped with betadine and draped, and an R.K. epidural needle (Epimed International, Farmers Branch, TX, USA) was introduced into caudal epidural space under fluoroscopic guidance. Upon confirmation of epidural needle placement, a lumbar epidurogram was executed, using approximately 1-5 mL of contrast. Filling defects were identified by examining contrast dispersion. In the event of intravascular or subarachnoid misdirection, needles were immediately repositioned. With the needle in the proper position, a Racz catheter (Epimed International) was advanced through its bore to sites of filling defects or pathology, as determined by MRI and preprocedural transforminal epidurography. Adhesiolysis was carried out as needed, with final needle positioning in epidural space, including lateral and ventral aspects. Given satisfactory placement, at least 3 mL of contrast was injected preliminarily. In the absence of subarachnoid, intravascular, or other extra-epidural filling and with satisfactory filling of epidural and targeted areas, a combination of 0.2% preservative-free ropivacaine 5 mL (naropine; AstraZeneca, London, UK), hyaluronidase 1,500 unit (Hrase; Kuhnil Pharmaceutical Co Ltd, Seoul, South Korea), and triamcinolone 40 mg was injected.
The first postprocedural follow-up was done at two weeks; a second epidurography was performed to assess any change in epidural filling defects. Outcome measurements were obtained using the visual analogue scale (VAS) score to assess the response to the procedure after two weeks, one month, and three months.
During the two weeks after procedures, all subjects received nonsteroidal anti-inflammatory drugs and muscle relaxants; in those who were nonresponsive, opioid or nonopioid analgesics may have been added after the first follow-up assessment.
Statistical Analysis
Wilcoxon's signed rank test was applied to assess differing mean values. The correlation between pain relief and status of postprocedural epidurogram was tested by Mann-Whitney U test. Statistical significance was set at a P value of less than 0.05.
Result
Of the 78 patients (mean age ¼ 60.9 years, range ¼ 34-85 years) with LSS selected for study, 47 men (63%) and 31 women (39%) were included. Spinal levels and sites affected are summarized in Table 1 , with L4/5 most frequently involved. In 21 patients (26.9%), epidural filling defects were identified on epidurography at baseline. Following percutaneous adhesiolysis, epidurographic filling defects were absent in 78% of patients.
Mean VAS score overall was not significantly associated with presence or absence of filling defects at two weeks, one month, and three months after percutaneous adhesiolysis ( Table 2 ). The percentage of patients who experienced pain relief (VAS scores greater than 50% of the baseline scores) was 50.0% at two weeks, 55.1% at one month, and 59.0% at three months after the procedure (Table 3) . In comparing postprocedural VAS scores and presence of epidurographic filling defects (yes or no), no statistically significant correlation was evident during followup (Table 3) .
Discussion
LSS typically is marked by a dynamic mechanical compression of dura and nerve root sheaths at the cauda equina level, with hyperemia, venous congestion, and nerve root edema as potential results [1] . Percutaneous epidural adhesiolysis has been advocated as an effective method of treating degenerative central lumbar stenosis [3, 5, 11] . Manchikanti et al. reportedly achieved substantial pain reduction (50%) in 76% of such patients in the year following this procedure [5] . A systematic review has also shown the merit of percutaneous adhesiolysis in managing chronic low back pain of level I or II-1 post-lumbar surgery [4] . Dissolution of aberrant adhesions and targeted delivery of agents (local anesthetics, steroids, and hypertonic sodium chloride solution) to affected sites may explain the benefits conferred, although current knowledge is limited with respect to managing back and/or lower extremity pain secondary to spinal stenosis [12] .
The current study, however, showed no correlation between pain relief and postprocedural epidurographic findings. Despite a lack of observable filling defects after adhesiolysis procedures, 17 of 78 patients reported no pain relief. Admittedly, the pathophysiology of lumbar stenosis is complex, with mechanical compression of nerve root or inflammatory effect as a major contributor but not the sole factor involved [13] . Our expectation was that following these procedures observable filling defects and poor pain relief would coincide. Still, the concept that epidural adhesions may cause pain [14, 15] or epidural fibrosis has already been questioned in lumbar post-discectomy syndrome [16] . Adhesions generally entail epidural perineural fibrosis with nerve entrapment by collagen fibers and subsequent narrowing of the lateral spinal canal. Arterial perfusion and venous return are interrupted as well [17] .
At least one earlier study has established that better spread of contrast (signifying lysis of scar) does not guarantee sustained pain relief [18] . Our findings are in agreement with this analysis, confirming that in the setting of spinal stenosis epidurographic improvement does not ensure successful outcomes after percutaneous epidural adhesiolysis. Indeed, filling defects may be attributable to nonpathologic scars or to functional adhesions, so that uniplanar spinal canal dimensions may not fully reflect the gravity of spinal [19] . Another potential factor in the disparity between symptoms and degree of spinal stenosis is the static images used to assess canal dimensions in what is clearly a dynamic [20] . Uden et al. [21] similarly demonstrated that myelographic features of stenosis in elderly patients do not necessarily imply that spinal stenosis is manifested clinically. An array of complex issues, including the possibility that a multiplicity of sites are involved, with cephalad and/or caudad extension of compression, may have bearing on whether or not spinal stenosis is in fact symptomatic [19] .
There were several limitations to the present study. Procedural outcomes were measured exclusively via subjective pain scores of patients. Furthermore, functional or psychological improvements were not measured, nor were medication reductions monitored. Finally, the relationship between postprocedural pain and epidurographic evidence of adhesions was investigated only after a two-week wait in follow-up that was otherwise short-term.
In conclusion, we found that improvement in epidurographic findings after percutaneous adhesiolysis did not correlate with levels of pain relief achieved in patients with LSS, warranting further studies of this therapeutic strategy.
